133 related articles for article (PubMed ID: 9356339)
1. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.
Kumar PK; Machida K; Urvil PT; Kakiuchi N; Vishnuvardhan D; Shimotohno K; Taira K; Nishikawa S
Virology; 1997 Oct; 237(2):270-82. PubMed ID: 9356339
[TBL] [Abstract][Full Text] [Related]
2. Specific RNA aptamers to NS3 protease domain of hepatitis C virus.
Fukuda K; Vishinuvardhan D; Sekiya S; Kakiuchi N; Shimotohno K; Kumar PK; Nishikawa S
Nucleic Acids Symp Ser; 1997; (37):237-8. PubMed ID: 9586087
[TBL] [Abstract][Full Text] [Related]
3. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
[TBL] [Abstract][Full Text] [Related]
4. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis C virus RNA replicons by peptide aptamers.
Trahtenherts A; Gal-Tanamy M; Zemel R; Bachmatov L; Loewenstein S; Tur-Kaspa R; Benhar I
Antiviral Res; 2008 Mar; 77(3):195-205. PubMed ID: 18243349
[TBL] [Abstract][Full Text] [Related]
6. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
7. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
[TBL] [Abstract][Full Text] [Related]
8. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
[TBL] [Abstract][Full Text] [Related]
9. Product inhibition of the hepatitis C virus NS3 protease.
Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
[TBL] [Abstract][Full Text] [Related]
10. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus.
Urvil PT; Kakiuchi N; Zhou DM; Shimotohno K; Kumar PK; Nishikawa S
Eur J Biochem; 1997 Aug; 248(1):130-8. PubMed ID: 9310370
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.
Zhong W; Ingravallo P; Wright-Minogue J; Skelton A; Uss AS; Chase R; Yao N; Lau JY; Hong Z
Virology; 1999 Sep; 261(2):216-26. PubMed ID: 10497107
[TBL] [Abstract][Full Text] [Related]
12. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.
Hwang B; Cho JS; Yeo HJ; Kim JH; Chung KM; Han K; Jang SK; Lee SW
RNA; 2004 Aug; 10(8):1277-90. PubMed ID: 15247433
[TBL] [Abstract][Full Text] [Related]
13. The nonstructural proteins of the hepatitis C virus: structure and functions.
Neddermann P; Tomei L; Steinkühler C; Gallinari P; Tramontano A; De Francesco R
Biol Chem; 1997 Jun; 378(6):469-76. PubMed ID: 9224925
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
15. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease.
Yang SH; Lee CG; Song MK; Sung YC
Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335
[TBL] [Abstract][Full Text] [Related]
16. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
17. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
[TBL] [Abstract][Full Text] [Related]
18. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
[TBL] [Abstract][Full Text] [Related]
19. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
[TBL] [Abstract][Full Text] [Related]
20. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor.
Eckart MR; Selby M; Masiarz F; Lee C; Berger K; Crawford K; Kuo C; Kuo G; Houghton M; Choo QL
Biochem Biophys Res Commun; 1993 Apr; 192(2):399-406. PubMed ID: 8387277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]